Kamari Pharma
Developer of a bio-pharmaceutical platform designed to develop proprietary small-molecule inhibitors. The company's platform uses a scientific approach to treat conditions of the skin with no current ...
Valuation
$42.8M
Market implied
Share Price
N/A
Total Raised
$48M
Last Round
N/A